GlucoTrack amends private placement warrants, ties exercise to shareholder approval under Nasdaq rules
G
GCTK• Warrant exercise tied to shareholder vote
GlucoTrack entered a securities purchase agreement on Aug. 4, 2026 for a private placement with a PIPE investor.
Closing included pre-funded warrants for common stock, plus common stock purchase warrants for common stock.
Warrant terms were amended on Sept. 14, 2026 to bar exercise until stockholder approval under Nasdaq Listing Rule 5635(d).
Share issuance under the common stock purchase warrants is now contingent on that stockholder vote.
•
GlucoTrack amends private placement warrants, ties exercise to shareholder approval under Nasdaq rules - GCTK News | Rallies
